Human medicines European public assessment report (EPAR): Lyxumia , lixisenatide, Diabetes Mellitus, Type 2, Date of authorisation: 31/01/2013, Revision: 12, Status: Authorised

SEMrush
Human medicines European public assessment report (EPAR): Lyxumia , lixisenatide, Diabetes Mellitus, Type 2, Date of authorisation: 31/01/2013, Revision: 12, Status: Authorised
[automaticbacklinks]